Dalhoff K, Poulsen H E
Department of Medicine A, Rigshospitalet, Copenhagen, Denmark.
Pharmacol Toxicol. 1993 Oct;73(4):215-8. doi: 10.1111/j.1600-0773.1993.tb01566.x.
The aim of the present study was to examine the effects of the hepatotoxic drug, acetaminophen, on the synthesis rates of glutathione, activated sulphate (PAPS, adenosine 3'-phosphate 5'-phosphosulphate) and the acetaminophen metabolites, acetaminophen-glutathione and acetaminophen-sulphate after inhibition of cytochrome P-450 drug oxidation by cimetidine in isolated rat hepatocytes. The synthesis rates of glutathione and PAPS were determined simultaneously by an established method based on trapping of radioactivity (35S) in the prelabelled glutathione and PAPS pools. Preincubation of the hepatocytes with 60 micrograms/ml cimetidine for 30 min. did not affect PAPS (1.71 versus 1.78 nmol/10(6) cells) nor glutathione concentration (16.0 versus 16.4 nmol/10(6) cells). The subsequent incubation with 5 mM acetaminophen resulted in decreased PAPS synthesis in the cimetidine treated cells [0.79 x 10(3) versus 0.92 x 10(3) nmol/(10(6) cells.hr)] (P < 0.05). There was no difference in PAPS concentration or acetaminophen-sulphate synthesis [1.73 versus 1.79 nmol/10(6) cells and 13.0 versus 12.9 nmol/(10(6) cells.hr), respectively]. Decreased PAPS synthesis may be related to decreased ATP supply or may be the result of a feed-back regulation due to diversion of sulphur from glutathione synthesis to sulfoxidation. The glutathione synthesis was not significantly affected by cimetidine treatment [57 x 10(3) versus 27 x 10(3) nmol/(10(6) cells.hr)]. As expected acetaminophen-glutathione synthesis decreased by 38% [1.66 versus 2.68 nmol/(10(6) cells.hr)] (P < 0.01). Also the glutathione concentration was lower in cimetidine treated cells [15.2 versus 15.9 nmol/10(6) cells] (P < 0.05). We have previously shown that glutathione synthesis was reduced if substrate availability decreased (acetaminophen concentration lowered).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是在西咪替丁抑制离体大鼠肝细胞中细胞色素P - 450药物氧化后,检测肝毒性药物对乙酰氨基酚对谷胱甘肽、活性硫酸盐(PAPS,腺苷3'-磷酸5'-磷酸硫酸盐)以及乙酰氨基酚代谢产物乙酰氨基酚 - 谷胱甘肽和乙酰氨基酚 - 硫酸盐合成速率的影响。谷胱甘肽和PAPS的合成速率通过基于捕获预标记的谷胱甘肽和PAPS池中的放射性(35S)的既定方法同时测定。将肝细胞与60微克/毫升西咪替丁预孵育30分钟,未影响PAPS(分别为1.71对1.78纳摩尔/10^6个细胞)和谷胱甘肽浓度(分别为16.0对16.4纳摩尔/10^6个细胞)。随后用5毫摩尔/升对乙酰氨基酚孵育导致西咪替丁处理的细胞中PAPS合成减少[0.79×10^3对0.92×10^3纳摩尔/(10^6个细胞·小时)](P < 0.05)。PAPS浓度或乙酰氨基酚 - 硫酸盐合成无差异[分别为1.73对1.79纳摩尔/10^6个细胞和13.0对12.9纳摩尔/(10^6个细胞·小时)]。PAPS合成减少可能与ATP供应减少有关,或者可能是由于硫从谷胱甘肽合成转向硫氧化导致的反馈调节的结果。西咪替丁处理对谷胱甘肽合成无显著影响[57×10^3对27×10^3纳摩尔/(10^6个细胞·小时)]。如预期的那样,乙酰氨基酚 - 谷胱甘肽合成减少了38%[1.66对2.68纳摩尔/(10^6个细胞·小时)](P < 0.01)。此外,西咪替丁处理的细胞中谷胱甘肽浓度也较低[15.2对15.9纳摩尔/10^6个细胞](P < 0.05)。我们之前已经表明,如果底物可用性降低(对乙酰氨基酚浓度降低),谷胱甘肽合成会减少。(摘要截短至250字)